Abstract
Hemorrhagic shock (HS) causes reduction of cellular energy stores, as measured by levels of ATP and ADP. Furthermore, energy depletion may cause mitochondrial damage, which in turn leads to cell death by apoptosis. The hypothesis of the present study is that by enhancing the recovery of cellular ATP and ADP and mitochondrial damage can be reduced, and the extent of apoptosis minimized. Crocetin, a carotenoid compound, appears to enhance the diffusion of oxygen in aqueous solution, and hence may improve energy stores both to the cell and within it. HS was produced in Sprague-Dawley rats by withdrawing blood from the carotid cannula until a mean arterial pressure of 35-40 mm Hg was reached, and then maintained by further withdrawals of blood for 30 and 60 min. Crocetin was administered 2-4 mg/kg in resuscitation fluid through venus cannula and the animals survived for 24-48 h after HS. Experiments designed to promote tissue reconstitution of ATP using crocetin indicate that these approaches are successful in increasing ATP post-hemorrhage and survival. Crocetin treatment also inhibited cellular damage as indicated by increase of Bcl-2 following decrease in cytosolic cytochrome c and caspase-3 after resuscitation. The prolonged energy deficit seen after hemorrhagic shock can produce late damage and rapid restoration of ATP levels to baseline can reduce apoptosis. In conclusions, crocetin can minimize the cellular damage as evidenced by apoptosis and increased the survival of rats.
Original language | English |
---|---|
Pages (from-to) | 139-146 |
Number of pages | 8 |
Journal | Molecular and Cellular Biochemistry |
Volume | 278 |
Issue number | 1-2 |
DOIs | |
Publication status | Published - Oct 2005 |
Externally published | Yes |
Bibliographical note
Funding Information:This work is supported by Midwest Biomedical Research Foundation at Kansas City, VA Medical Center. Thanks to Dr Donald R. Campbell of Saint Luke’s Hospital, Kansas City and Dr Charles W. Van Way of Truman Medical Center, Kansas City for their support during the development of this manuscript.
ASJC Scopus Subject Areas
- Molecular Biology
- Clinical Biochemistry
- Cell Biology
PubMed: MeSH publication types
- Journal Article
- Research Support, Non-U.S. Gov't
- Research Support, U.S. Gov't, Non-P.H.S.